ICD-10 Specific code A56.1: Chlamydial infection of pelviperitoneum and other genitourinary organs

Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.

Translations

Language Translation
Flag for English language  English Chlamydial infection of pelviperitoneum and other genitourinary organs
Flag for French language  French Infection ร  Chlamydia, pelvi-pรฉritonรฉale et des autres organes gรฉnito-urinaires

Hierarchical position

Level Code Title
1 I Certain infectious and parasitic diseases
2 A50-A64 Infections with a predominantly sexual mode of transmission
3 A56 Other sexually transmitted chlamydial diseases
4 A56.1 Chlamydial infection of pelviperitoneum and other genitourinary organs

Indicated medicines

Active Ingredient Description
Minocycline

Minocycline is a semi-synthetic derivative of tetracycline. Minocycline inhibits protein synthesis in susceptible bacteria. In common with other tetracyclines it is primarily bacteriostatic and has a similar spectrum of activity to other tetracyclines.

Ofloxacin

Ofloxacin is a quinolone-carboxylic acid derivative with a wide range of antibacterial activity against both Gram-negative and Gram-positive organisms. The primary mode of action of the quinolones is the specific inhibition of bacterial DNA gyrase. This enzyme is required for DNA replication, transcription, repair and recombination.

Spiramycin

Antibacterial antibiotic belonging to the macrolides family. Spiramycin inhibits translocation by binding to bacterial 50S ribosomal subunits with an apparent 1:1 stoichiometry. This antibiotic is a potent inhibitor of the binding to the ribosome of both donor and acceptor substrates. Spiramycin induces rapid breakdown of polyribosomes, an effect which has formerly been interpreted as occurring by normal ribosomal run-off followed by an antibiotic-induced block at or shortly after initiation of a new peptide.